Home
About
Overview
Sharing Data
ORCID
Help
History (3)
ClpAP is an auxiliary protease for DnaA degradation in Caulobacter crescentus.
Drug Resistance, Viral
Will Obesity Treatment Reimbursement Benefit Those at Highest Risk?
See All 3 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Will Obesity Treatment Reimbursement Benefit Those at Highest Risk?
Bennett GG, Steinberg DM, Pagoto SL. Will Obesity Treatment Reimbursement Benefit Those at Highest Risk? Am J Med. 2015 Jul; 128(7):670-1.
View in:
PubMed
subject areas
Body Mass Index
Cost-Benefit Analysis
Female
Health Care Costs
Humans
Insurance, Health, Reimbursement
Male
Medicaid
Medicare
Needs Assessment
Obesity
Obesity, Morbid
Risk Assessment
Treatment Outcome
United States
Weight Loss
authors with profiles
Sherry L Pagoto PhD